These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1309 related articles for article (PubMed ID: 25194353)
1. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
2. Development of Targeted Nanoscale Drug Delivery System for Osteoarthritic Cartilage Tissue. Jiang T; Kan HM; Rajpura K; Carbone EJ; Li Y; Lo KW J Nanosci Nanotechnol; 2018 Apr; 18(4):2310-2317. PubMed ID: 29442897 [TBL] [Abstract][Full Text] [Related]
3. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
4. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system. Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691 [TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614 [TBL] [Abstract][Full Text] [Related]
6. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
8. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation. Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949 [TBL] [Abstract][Full Text] [Related]
9. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
10. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
11. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
13. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin. Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241 [TBL] [Abstract][Full Text] [Related]
14. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related]
16. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation. Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775 [TBL] [Abstract][Full Text] [Related]
17. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897 [TBL] [Abstract][Full Text] [Related]
18. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. Choi SW; Kim JH J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158 [TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
20. Selective drug delivery system to bone: small peptide (Asp)6 conjugation. Kasugai S; Fujisawa R; Waki Y; Miyamoto K; Ohya K J Bone Miner Res; 2000 May; 15(5):936-43. PubMed ID: 10804024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]